Please select the eligibility criteria that correspond to the clinical trial below.
Title: Preconception Risk Evaluation Via Electronic Medical Record Notification of Teratogenic Risks
Brief Summary: This study will use a factorial design randomized controlled trial to (1)compare multi-faceted decision support (intervention) to streamlined clinical alerts (control) and (2) evaluate whether collecting information about women's risk of pregnancy using a networked tablet computer (intervention) is superior to the way clinicians usually collect this information (control).

Over the course of 1 year, we will abstract data from the electronic medical record when study clinicians prescribe teratogenic medications, conduct phone interviews with women prescribed medications by participating clinicians, and survey participating clinicians about their satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction with the counseling they received, and (4) report more satisfaction with the decision support they received.


Options:
A: Inclusion Criteria:

* 18 years or older
* admitted to any medical ward, telemetry or cardiac care unit
* identified as a smoker by the nurse or physician in the admitting EMR
* treated by a study physician
* able to give written informed consent

Exclusion Criteria:

* inability to read or understand English or Spanish
* lacks capacity to give informed consent
* currently receiving formal tobacco dependence treatment
* current suicide or homicide risk
* current psychotic disorder or life-threatening or unstable medical or psychiatric condition within past 6 months
* unable to provide 2 telephone contact numbers
* unwilling to follow up per study protocol, including release of information to assess treatment engagement at 30-days
* live outside of New Haven County
* leaving the hospital against medical advice
* history of clinically significant allergic reaction to nicotine replacement therapies, varenicline or bupropion
* use of an investigational drug within 30 days
* use of tobacco products other than cigarettes
* women of childbearing potential who are pregnant, nursing, or sexually active and not practicing effective contraception (oral injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide)
* do not have access to a phone with a CT area code (required to use the CT Tobacco Quitline)
B: Inclusion Criteria:

* HIV infected
* Followed in the Massachusetts General Hospital HIV clinic.

Exclusion Criteria:
C: Inclusion Criteria:

* Women aged 18-45 seen at a participating primary care clinic

Exclusion Criteria:

* Non-English speakers
D: Inclusion Criteria:

* Physicians are eligible for inclusion if they are general practitioners or family physicians in full-time (≥ 4 days/week), fee-for-service practice in Quebec
* Patients where the study physician has written or dispensed prescriptions for beta2-agonists, anti-leukotrienes, or inhaled corticosteroids, and has verified the diagnosis of asthma

Exclusion Criteria:

* Younger than 5 years old
* Diagnosis of COPD

Answer: C